Wordt geladen...
Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors
Aberrant forms of the anaplastic lymphoma kinase (ALK) have been implicated in the pathogenesis of multiple human cancers, where ALK represents a rational therapeutic target in these settings. In this study, we report the identification and biological characterization of X-376 and X-396, two potent...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138877/ https://ncbi.nlm.nih.gov/pubmed/21613408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-3879 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|